Focus: Mission Pharmacal is a San Antonio-based specialty pharma company focused on small molecules and consumer products across hematology, neurology, and nephrology. The company operates as a private entity with a highly concentrated revenue base.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Stable — net +4 jobs in 30d
7 added, 3 removed. Backfill posture.
Mission Pharmacal offers stable, niche pharmaceutical expertise but carries significant single-product risk and limited growth opportunities for career advancement.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Mission Pharmacal
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Mission Pharmacal's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Company's sole revenue driver and only marketed product with meaningful reimbursement; patent cliff not until 2038 provides long runway.
Generic antihistamine in post-LOE phase; represents legacy consumer product line with minimal revenue contribution.
Commodity potassium iodide products with multiple generic competitors; government stockpiling driven, not market-driven demand.
Generic neurological agent with no differentiation; mature market with established competitors.
2 discontinued, 2 duplicate formulations not shown
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles